FVE is proud to announce the release of our new FIP brochure. This brochure provides veterinarians across Europe with an essential update on legal and regulated treatment avenues for Feline Infectious Peritonitis (FIP).
With recent advancements, extemporaneous GS-441524-based treatments are now legally available in France, providing a controlled alternative to previous unregulated options. This development marks an important milestone for veterinary professionals, allowing for safe and effective FIP treatments under EU regulations.
Brochure Highlights
- GS-441524 Availability: New extemporaneous products, such as those offered by Pharmacy Delpech in France, provide veterinarians with an authorized option to treat FIP, reducing reliance on unregulated sources.
- Streamlined Treatment Protocols: The brochure explores emerging research that may allow for a shortened 42-day treatment duration, making FIP treatment more accessible and manageable for pet owners.
- FVE Advocacy for Regulatory Alignment: FVE continues to advocate for harmonized regulations across EU Member States to ensure veterinarians have consistent access to safe, approved FIP treatments, ensuring the welfare of cats across Europe.
Explore the FVE FIP brochure for an overview of available treatments, scientific insights, and FVE’s ongoing work to support European veterinarians in managing FIP effectively.
